Milestones
2022
Bora Biologics established and acquired Eden Biologics CDMO assets
Bora acquired TWi Pharmaceuticals
2020
Acquire GSK’s Mississauga, Ontario (Canada) facility
2018
Acquired Impax Laboratories Inc. Taiwan Subsidiary and entered US CDMO market
2017
Invested in Yuta Health to license CHC and OTC products of Eisai and SSP pharmaceutical in Taiwan
Completed initial public offering at Taipei Exchange (GreTai Securities Market)
Completed initial public offering at Taipei Exchange (GreTai Securities Market)
2014
Bora Pharmaceuticals begins public trading on the GTSM ESB
Acquired Union Chemicals Co., Ltd.
Established official Research and Development Laboratory
Acquired Union Chemicals Co., Ltd.
Established official Research and Development Laboratory
2013
Acquired Tainan manufacturing site from Japanese Company
2007
Bora Pharmaceuticals established